AKT1 and leukemia: For the first time, we showed that BJe induces anticancer effects against the human leukemia monocytic THP-1 cell line, causing cell cycle arrest in S phase and triggering the apoptotic machinery, via targeting of the SIRT2/AKT/p53 pathway.